Keep pulling the thread on Arvind Krishna.
Arvind Krishna stated that IBM is on track to achieve quantum advantage by the end of 2026.
In April 2026, an IBM quantum system simulated a 12,000-atom molecule, representing half of the protein trypsin.
Arvind Krishna asserts that simulating molecules at the 12,000-atom scale and larger is not possible using classical supercomputers.
IBM has committed to invest approximately $10 billion in its quantum computing program.
The U.S. federal government has provided IBM with $1 billion in funding for its quantum computing initiatives.
Arvind Krishna estimates the United States currently has a lead of approximately two years over China in quantum computing development.
In its most recent acquisition, IBM utilized AI to eliminate approximately 60% of the acquired company's General and Administrative (G&A) expenses on day one.
IBM has committed approximately $5 billion to a cybersecurity initiative named Project Lightwell.
Arvind Krishna predicts that IBM's investments in quantum and cybersecurity will generate 'incredible returns' within the next two to three years.
IBM set a target two years prior to mid-2026 to achieve quantum advantage using its hardware by the end of 2026.
IBM partners Cleveland Clinic and Oak Ridge National Laboratory are demonstrating early progress towards quantum advantage.
Arvind Krishna predicts the first commercial applications of quantum advantage will be in materials science, including developing new magnetic materials, lubricants, and better EV batteries.